Title: Babies in waiting: Why increasing the IVF age cut-off might lead to fewer wanted pregnancies in the presence of procrastination Authors: Paul Dolan, Caroline Rudisil Publisher: Health Policy (2014). View Publication
Title: Vouchers versus lotteries: what works best in promoting chlamydia screening? A cluster randomised controlled trial Authors: Niza C, Rudisill C, Dolan P Publisher: Applied Economic Perspectives and Policy ISSN: 10.1093/aepp/ppt033 View Publication
Title: The effect of financial incentives on chlamydia testing rates: Evidence from a randomized experiment Authors: Caroline Rudisill, Paul Dolan Publisher: Social Science & Medicine Corresponding ISSN: View Publication
Title: Pay them if it works: Discrete choice experiments on the acceptability of financial incentives to change health related behaviour Authors: Promberger M, Dolan P, Marteau T Publisher: Social Science and Medicine
Title: Influencing financial behaviour: from changing minds to changing contexts Authors: Dolan P, Elliott A, Metcalfe R and Vlaev I Publisher: Journal of Behavioral Finance ISSN: 1542-7560 View Publication
Title: Explaining attitudes towards ambiguity: an experimental test of the comparative ignorance hypothesis Authors: Dolan, Paul and Jones, Martin Publisher: Scottish journal of political economy, 51 (3). pp. 281-301 ISSN: 0036-9292 View Publication
Abstract: Many theories have been put forward to explain attitudes towards ambiguity. This paper reports on an experiment designed to test for the existence of Comparative Ignorance when it is tested over events with a range of different likelihoods. A total of 93 subjects valued a series of gambles, one of which was played out for real. The results do not lend support to the theory, although the relationship between risk and ambiguity does appear to correspond with other theories and previous empirical work.
Title: Prescribing by general practitioners after an osteoporotic fracture Authors: Torgerson, D. J and Dolan, Paul Publisher: Annals of the rheumatic diseases, 57 (6). pp. 378-379. ISSN: 0003-4967 View Publication
Abstract: OBJECTIVES Osteoporosis is a major cause of morbidity and cost. Patients sustaining one osteoporotic fracture are at increased risk of having another fracture. The objective of this study was to examine the use of “bone drugs” for the prevention of further osteoporotic fractures among patients who have had a “typical” osteoporotic fracture. METHODS This study took a random sample of 300 women aged 50 and over who had sustained either a vertebral, hip or Colles fracture in 1995 from the General Practice Research Database (GPRD) and compared their use of bone drugs with 300 age and practice matched controls. RESULTS Compared with age and practice matched control patients only vertebral fracture patients showed a statistically significant increase in the use of bone drugs in the year after fracture (39% and 2% for cases and controls respectively; 95% CI of difference 27% to 47%). Etidronate was the most commonly used compound. CONCLUSION The majority of patients sustaining an osteoporotic fracture are not prescribed any pharmaceutical agents for the secondary prevention of fracture one year after a primary fracture.